Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

A new policy shift is reshaping the landscape for GLP-1 drugs, signaling major financial effects for Medicare, insurers, and ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The Centers for Medicare and Medicaid Services (CMS) said that deal is expected to supersede the prices negotiated under the ...

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

A deal between President Donald Trump and Novo Nordisk A/S to slash Ozempic and Wegovy prices under a most-favored-nation ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...